Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest 2001-01, Vol.119 (1), p.64S-94S
Hauptverfasser:	Hirsh, Jack, Warkentin, Theodore E., Shaughnessy, Stephen G., Anand, Sonia S., Halperin, Jonathan L., Raschke, Robert, Granger, Christopher, Ohman, E. Magnus, Dalen, James E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angina pectoris Angina, Unstable - drug therapy Angioplasty Anticoagulants Anticoagulants - adverse effects Anticoagulants - pharmacokinetics Anticoagulants - pharmacology Anticoagulants - therapeutic use Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Coronary Disease - drug therapy Enzymes Heart attacks Heparin - adverse effects Heparin - pharmacokinetics Heparin - pharmacology Heparin - therapeutic use Heparin, Low-Molecular-Weight - adverse effects Heparin, Low-Molecular-Weight - pharmacokinetics Heparin, Low-Molecular-Weight - pharmacology Heparin, Low-Molecular-Weight - therapeutic use Humans Medical sciences Molecular weight Myocardial Infarction - drug therapy Pharmacokinetics Pharmacology. Drug treatments Pulmonary embolisms Thromboembolism Thrombosis Venous Thrombosis - drug therapy Venous Thrombosis - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!